Written Testimony on FY 2020 Appropriations for NIH HIV/AIDS Research Agenda
April 8, 2019 — This written testimony for Fiscal Year 2020 for the National Institutes of Health (NIH) was submitted to the U.S. House of Representatives Labor, Health and Human Services, and Education (LHHS) Subcommittee. The testimony was submitted by representatives of AVAC and Treatment Action Group, and prepared by the Research Working Group of the Federal AIDS Policy Partnership (FAPP)

Letter Asking to Include TB in President’s Plan to End HIV Epidemic
March 27, 2019 — TAG and our community partners in the Tuberculosis Roundtable submitted a letter urging HHS Secretary Alex Azar and Assistant Secretary for Health Brett Giroir to include tuberculosis in the implementation of the President’s plan to end the HIV epidemic by 2030.

Letter Urging Support at UN Commission on Narcotic Drugs for Measures to Prevent & Treat Hep C Among People Who Use Drugs
March 20, 2019 — TAG and our community partners submitted letters urging the US Delegation to the UN Commission on Narcotic Drugs to express support for draft resolution E/CN.7/2019/L.4.

TAG Testimony to House SFOPS Appropriations Subcommittee
March 15, 2019 — Treatment Action Group (TAG), on behalf of the Tuberculosis (TB) Roundtable coalition, submitted this testimony to the House of Representatives Committee on Appropriations, Subcommittee on State, Foreign Operations and Related Programs for consideration in fiscal year (FY) 2020 appropriations. The TB Roundtable is comprised of organizations focused on federal advocacy for the domestic and global elimination of TB. submitted by Suraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director On behalf of the Tuberculosis Roundtable

Letters of Support – Protecting Equitable Health for all New Yorkers, Including Undocumented Adults and Those with Temporary Protected Status (TPS)
March 5, 2019 — TAG submitted the following letters of support to the NY State assembly Health Committee Members to support Assembly Bills A.3316 (S. 1809) and A.5974 (S. 3900).

A Lower Price for Rifapentine Is Just a Start – Communities Need More Than Discounts to Access TB Preventive Therapy
March 5, 2019 — October 31, 2019 — Civil society and community-based organizations issued this letter welcoming the availability of lower-priced rifapentine, which is an essential medicine for preventing TB. However,  while all the organizations agree that this discou…

Verbal Comment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
February 5, 2019 — On January 31, 2019, TAG delivered a verbal comment at a public meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), urging the council on the need to prioritize TB as an antimicrobial resistant (AMR) threat, and for increased research funding across U.S. agencies to counter drug-resistant TB.

Public Comment on NIDA Strategic Plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse, and Addiction
January 25, 2019 — TAG recently submitted a public comment to the National Institute on Drug Abuse (NIDA) at the National Institute of Health to inform a strategic plan it is developing to support research at the intersection of HIV and drug use.

Public Comment on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 22, 2019 — TAG recently submitted this public comment on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions, highlighting the need to mitigate national supply challenges and shortages of critical TB drugs.

TAG and 75 Other Orgs Send Fetal Tissue Research Letter To Alex Azar
January 14, 2019 — Following news of the Trump Administration’s abrupt review of HIV treatment and cure research using fetal tissue, TAG and 75 other organizations signed and sent a letter to HHS Secretary Azar on December 21, 2018.